相关实验视频
Updated: Jul 25, 2025

08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
4.8K
今年最重要的进展:尿生殖系统癌症
Francesca Jackson-Spence1, Matthew Young1, Christopher Sweeney2
1Barts Cancer Institute, Queen Mary University of London, London, UK.
Cancer
|June 28, 2023
概括
泌尿癌治疗的最新进展为人们带来了新的希望. 新型免疫疗法,向药物和组合疗法正在改善脏,膀和前列腺癌的存活率,特别是在晚期.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 医学科学 医学科学 医学科学
背景情况:
- 在治疗泌尿道癌症方面取得了重大进展.
- 新的疗法正在改善患者的治疗结果,特别是在晚期疾病中.
研究的目的:
- 审查泌尿瘤学中改变实践的治疗方法.
- 为了突出细胞癌,尿道癌和前列腺癌治疗的最新进展.
主要方法:
- 审查最近的临床试验数据和出版物.
- 专注于免疫疗法,向药物和组合疗法.
- 讨论新型药物,如贝尔祖提凡,抗体药物合物和放射性连接体疗法.
主要成果:
- 免疫疗法在细胞癌中表现有前途.
- 抗体药物联合体在泌尿器癌中表现出活性.
- 组合疗法和新型药物正在改善前列腺癌的治疗结果.
结论:
- 最近的进展正在改变尿道癌症的治疗.
- 新的治疗策略为患者提供了更好的生存效益.
- 新兴的治疗方法预计将进一步改变临床实践.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Urinary Tract Calculi III: Medical Management
9
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
9
Nursing Assessment of the Genitourinary System I: Health History
32
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
32
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
15
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
15
Urinary Tract Calculi VI: Surgical Management
11
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
11
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

